GlassScriptPhysician profile
Mary Anne Brown
NPI 1467430272
$1,974.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $83.21 · 2021: $241 · 2022: $573 · 2023: $543 · 2024: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $458.54 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $358.37 | 2021-2024 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $222.36 | 2019-2022 | |
| Glaxosmithkline, LLC. | $144.84 | 2020-2024 | Bexsero |
| Tris Pharma INC | $141.79 | 2019-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $110.21 | 2019-2024 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $110.02 | 2021-2023 | |
| Cranial Technologies, INC | $97.73 | 2019-2024 | Doc Band |
| Sanofi Pasteur INC. | $63.19 | 2021-2024 | |
| Genentech USA, INC. | $47.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.49 | 2022-2023 | Varivax, Vaxneuvance, Rotateq |
| Pfizer INC. | $37.54 | 2022-2024 | |
| Abbvie INC. | $28.15 | 2022 | |
| Sobi, INC | $27.27 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $22.97 | 2019 | |
| Kaleo, INC. | $19.42 | 2021 | |
| Shire North American Group INC | $16.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.